The ROE as of December 2025 (TTM) for Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) is 8.69%

According to Chengdu Easton Biopharmaceuticals Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 8.69%. This represents a change of 302.96% compared to the average of 2.16% of the last 4 quarters.

Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) Historical ROE (quarterly & annually)

How has 688513.SS ROE performed in the past?

The mean historical ROE of Chengdu Easton Biopharmaceuticals Co., Ltd. over the last ten years is 12.96%. The current 8.69% ROE has changed -32.92% with respect to the historical average. Over the past ten years (40 quarters), 688513.SS's ROE was at its highest in in the June 2020 quarter at 7.06%. The ROE was at its lowest in in the June 2015 quarter at 0%.

Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) ROE by Quarter and Year

Discovering the peaks and valleys of Chengdu Easton Biopharmaceuticals Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) Average ROE

How has 688513.SS ROE performed in the past?

The current ROE of Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) ROE vs. Peers

How is 688513.SS’s ROE compared to its peers?

Chengdu Easton Biopharmaceuticals Co., Ltd.’s ROE is less than Shanghai Haohai Biological Technology Co., Ltd. (6.84%), less than Chengdu Kanghua Biological Products Co., Ltd. (5.25%), less than Aurisco Pharmaceutical Co.,Ltd. (17.43%), less than Anhui Huaheng Biotechnology Co., Ltd. (7.14%), less than Zhejiang Ausun Pharmaceutical Co., Ltd. (7.85%), less than Zhejiang Jolly Pharmaceutical Co.,LTD (19.80%), less than Chengzhi Shareholding Co., Ltd. (0.65%), less than Chengdu Olymvax Biopharmaceuticals Inc. (6.89%), less than China Resources Boya Bio-pharmaceutical Group Co., Ltd. (4.30%), less than Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (15.66%),

Build a custom stock screener for Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chengdu Easton Biopharmaceuticals Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chengdu Easton Biopharmaceuticals Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.